News

Arlington Neonatal Intensive Care is a two-physician practice that staffs the Level III neonatal intensive care unit (NICU) at Texas Health Arlington Memorial Hospital, which has annual patient

In addition, Terrance Gregg, DexCom’s president and CEO, also purchased 150,000 additional shares of common stock in this offering at a per share price of $3.12, which represents

The Phase III Atlas study was stopped early on the recommendation of an independent data safety monitoring board after a pre-planned interim analysis showed that combining Tarceva and

Net loss was $5.9 million, or $(0.10) per share, which against revenue of $40.4 million and a net loss of $5.3 million, or $(0.10) per share, in the

MEDI-546 will be studied in patients with scleroderma, a chronic autoimmune disease characterized by hardening and thickening of the skin and other organs. MedImmune has previously entered into

In the company’s ongoing Phase I/II clinical trial, a one-time administration of Epodure, producing and delivering the low dose of 18-25IU/kg/day of the protein erythropoietin (EPO), was sufficient

‘ON’ time represents periods when Parkinson’s patients experience their best level of motor functioning. According to the company, the two safinamide treatment groups of the study (receiving either

In India the company plans to begin marketing the oral herpes device pursuant to the exclusive worldwide distribution rights it acquired from NeuroMed, as previously announced. The company

Under the agreement, eResearchTechnology (ERT) and Integrium will deliver a combined solution to meet the increased demand for centralized cardiac safety and ambulatory blood pressure monitoring (ABPM) services